235 related articles for article (PubMed ID: 24978392)
1. Sex steroids and gender differences in nonmuscle invasive bladder cancer.
Lucca I; Fajkovic H; Klatte T
Curr Opin Urol; 2014 Sep; 24(5):500-5. PubMed ID: 24978392
[TBL] [Abstract][Full Text] [Related]
2. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Prognostication Using Conditional Recurrence and Progression Estimates for Patients with Nonmuscle Invasive Bladder Cancer.
Leitner CV; Ederer IA; de Martino M; Hofbauer SL; Lucca I; Mbeutcha A; Mathieu R; Haitel A; Susani M; Shariat SF; Klatte T
J Urol; 2016 Jul; 196(1):46-51. PubMed ID: 26835832
[TBL] [Abstract][Full Text] [Related]
4. Smoking and smoking cessation effects on oncological outcomes in nonmuscle invasive bladder cancer.
Simonis K; Shariat SF; Rink M;
Curr Opin Urol; 2014 Sep; 24(5):492-9. PubMed ID: 24887046
[TBL] [Abstract][Full Text] [Related]
5. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNA in bladder cancer: a specific focus upon high-risk nonmuscle invasive disease.
Noon AP; Catto JW
Curr Opin Urol; 2014 Sep; 24(5):506-11. PubMed ID: 25051024
[TBL] [Abstract][Full Text] [Related]
7. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
Dobruch J; Daneshmand S; Fisch M; Lotan Y; Noon AP; Resnick MJ; Shariat SF; Zlotta AR; Boorjian SA
Eur Urol; 2016 Feb; 69(2):300-10. PubMed ID: 26346676
[TBL] [Abstract][Full Text] [Related]
8. The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder.
Boorjian SA; Zhu F; Herr HW
BJU Int; 2010 Aug; 106(3):357-61. PubMed ID: 20002665
[TBL] [Abstract][Full Text] [Related]
9. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer.
Matsumoto K; Kikuchi E; Shirakawa H; Hayakawa N; Tanaka N; Ninomiya A; Miyajima A; Nakamura S; Oya M
BJU Int; 2012 Dec; 110(11 Pt B):E508-13. PubMed ID: 22574662
[TBL] [Abstract][Full Text] [Related]
10. Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer.
Klatte T; Xylinas E; Rieken M; Kluth LA; Rouprêt M; Pycha A; Fajkovic H; Seitz C; Karakiewicz PI; Lotan Y; Babjuk M; de Martino M; Scherr DS; Shariat SF
J Urol; 2014 May; 191(5):1238-43. PubMed ID: 24333243
[TBL] [Abstract][Full Text] [Related]
11. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
Yutkin V; Pode D; Pikarsky E; Mandelboim O
J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
[TBL] [Abstract][Full Text] [Related]
12. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
[TBL] [Abstract][Full Text] [Related]
13. Superficial bladder cancer: decreasing the risk of recurrence.
Grossman HB
Oncology (Williston Park); 1996 Nov; 10(11):1617-24; discussion 1624, 1627-8. PubMed ID: 8953583
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
van Rhijn BW; Liu L; Vis AN; Bostrom PJ; Zuiverloon TC; Fleshner NE; van der Aa MN; Alkhateeb SS; Bangma CH; Jewett MA; Zwarthoff EC; Bapat B; van der Kwast TH; Zlotta AR
BJU Int; 2012 Oct; 110(8):1169-76. PubMed ID: 22448597
[TBL] [Abstract][Full Text] [Related]
15. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinoma of the bladder and the upper tract: disparate twins.
Green DA; Rink M; Xylinas E; Matin SF; Stenzl A; Roupret M; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2013 Apr; 189(4):1214-21. PubMed ID: 23023150
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often?
Schmidbauer J; Lindenau G
Curr Opin Urol; 2008 Sep; 18(5):504-7. PubMed ID: 18670275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
